{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T15:13:15Z","timestamp":1771168395231,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA132641"],"award-info":[{"award-number":["CA132641"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016087"],"award-info":[{"award-number":["P30CA016087"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA009161"],"award-info":[{"award-number":["T32CA009161"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012636","name":"New York State Stem Cell Science","doi-asserted-by":"publisher","award":["C026719"],"award-info":[{"award-number":["C026719"]}],"id":[{"id":"10.13039\/100012636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD010751"],"award-info":[{"award-number":["S10OD010751"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA181111"],"award-info":[{"award-number":["CA181111"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-16-033-01-DDC"],"award-info":[{"award-number":["RSG-16-033-01-DDC"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["T32AR064184"],"award-info":[{"award-number":["T32AR064184"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG056169"],"award-info":[{"award-number":["AG056169"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["K08AR069099"],"award-info":[{"award-number":["K08AR069099"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41388-019-0841-3","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T21:55:38Z","timestamp":1561499738000},"page":"5766-5777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone"],"prefix":"10.1038","volume":"38","author":[{"given":"Evelyne","family":"Tassone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Bradaschia-Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Sastre-Perona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Marie","family":"Josephson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Khodadadi-Jamayran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Kahler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Ossowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8409-8513","authenticated-orcid":false,"given":"Philipp","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Schober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine L.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"key":"841_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"841_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1464-410X.2006.06670.x","volume":"99","author":"I Vela","year":"2007","unstructured":"Vela I, Gregory L, Gardiner EM, Clements JA, Nicol DL. Bone and prostate cancer cell interactions in metastatic prostate cancer. BJU Int 2007;99:735\u201342.","journal-title":"BJU Int"},{"key":"841_CR3","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1242\/jcs.063032","volume":"124","author":"JC Crockett","year":"2011","unstructured":"Crockett JC, Rogers MJ, Coxon FP, Hocking LJ, Helfrich MH. Bone remodelling at a glance. J Cell Sci 2011;124:991\u20138.","journal-title":"J Cell Sci"},{"key":"841_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00223-017-0350-8","volume":"102","author":"SH Park","year":"2018","unstructured":"Park SH, Keller ET, Shiozawa Y. Bone marrow microenvironment as a regulator and therapeutic target for prostate cancer bone metastasis. Calcif Tissue Int 2018;102:152\u201362.","journal-title":"Calcif Tissue Int"},{"key":"841_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biocel.2016.08.003","volume":"79","author":"NA Sims","year":"2016","unstructured":"Sims NA. Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption. Int J Biochem Cell Biol 2016;79:14\u201323.","journal-title":"Int J Biochem Cell Biol"},{"key":"841_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coph.2016.02.013","volume":"28","author":"S Gooding","year":"2016","unstructured":"Gooding S, Edwards CM. New approaches to targeting the bone marrow microenvironment in multiple myeloma. Curr Opin Pharmacol 2016;28:43\u20139.","journal-title":"Curr Opin Pharmacol"},{"key":"841_CR7","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1158\/0008-5472.CAN-16-0497","volume":"77","author":"S Nandana","year":"2017","unstructured":"Nandana S, Tripathi M, Duan P, Chu C-Y, Mishra R, Liu C, et al. Bone metastasis of prostate cancer can be therapeutically targeted at the TBX2-WNT signaling axis. Cancer Res 2017;77:1331\u201344.","journal-title":"Cancer Res"},{"key":"841_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ccell.2017.02.003","volume":"31","author":"JB Wu","year":"2017","unstructured":"Wu JB, Yin L, Shi C, Li Q, Duan P, Huang J-M, et al. MAOA-dependent activation of Shh-IL6-RANKL signaling network promotes prostate cancer metastasis by engaging tumor-stromal cell interactions. Cancer Cell 2017;31:368\u201382.","journal-title":"Cancer Cell"},{"key":"841_CR9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nrurol.2015.90","volume":"12","author":"J-J Body","year":"2015","unstructured":"Body J-J, Casimiro S, Costa L. Targeting bone metastases in prostate cancer: improving clinical outcome. Nat Rev Urol 2015;12:340\u201356.","journal-title":"Nat Rev Urol"},{"key":"841_CR10","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/j.celrep.2018.11.065","volume":"25","author":"X Xiong","year":"2018","unstructured":"Xiong X, Schober M, Tassone E, Khodadadi-Jamayran A, Sastre Perona A, Zhou H, et al. KLF4, A gene regulating prostate stem cell homeostasis, is a barrier to malignant progression and predictor of good prognosis in prostate cancer. Cell Rep 2018;25:3006\u201320.","journal-title":"Cell Rep"},{"key":"841_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663\u201376.","journal-title":"Cell"},{"key":"841_CR12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1128\/MCB.06306-11","volume":"32","author":"YN Liu","year":"2012","unstructured":"Liu YN, Abou-Kheir W, Yin JJ, Fang L, Hynes P, Casey O, et al. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor \u03b2-initiated prostate cancer epithelial-mesenchymal transition. Mol Cell Biol 2012;32:941\u201353.","journal-title":"Mol Cell Biol"},{"key":"841_CR13","doi-asserted-by":"publisher","first-page":"10182","DOI":"10.1158\/0008-5472.CAN-10-2414","volume":"70","author":"J Wang","year":"2010","unstructured":"Wang J, Place RF, Huang V, Wang X, Noonan EJ, Magyar CE, et al. Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res 2010;70:10182\u201391.","journal-title":"Cancer Res"},{"key":"841_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc1780","volume":"6","author":"BD Rowland","year":"2005","unstructured":"Rowland BD, Peeper DS. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 2005;6:11\u201323.","journal-title":"Nat Rev Cancer"},{"key":"841_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc3582","volume":"13","author":"M-P Tetreault","year":"2013","unstructured":"Tetreault M-P, Yang Y, Katz JP. Kr\u00fcppel-like factors in cancer. Nat Rev Cancer 2013;13:701\u201313.","journal-title":"Nat Rev Cancer"},{"key":"841_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.gene.2017.02.025","volume":"611","author":"AM Ghaleb","year":"2017","unstructured":"Ghaleb AM, Yang VW. Kr\u00fcppel-like factor 4 (KLF4): what we currently know. Gene 2017;611:27\u201337.","journal-title":"Gene"},{"key":"841_CR17","first-page":"16","volume":"17","author":"ME Kaighn","year":"1979","unstructured":"Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979;17:16\u201323.","journal-title":"Invest Urol"},{"key":"841_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.79","volume":"5","author":"M-K Siu","year":"2016","unstructured":"Siu M-K, Suau F, Chen W-Y, Tsai Y-C, Tsai H-Y, Yeh H-L, et al. KLF4 functions as an activator of the androgen receptor through reciprocal feedback. Oncogenesis 2016;5:e282.","journal-title":"Oncogenesis"},{"key":"841_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000024522","volume":"18","author":"OH Sanchez-Sweatman","year":"1998","unstructured":"Sanchez-Sweatman OH, Orr FW, Singh G. Human metastatic prostate PC3 cell lines degrade bone using matrix metalloproteinases. Invasion Metastasis 1998;18:297\u2013305.","journal-title":"Invasion Metastasis"},{"key":"841_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/pros.20678","volume":"68","author":"AP Armstrong","year":"2007","unstructured":"Armstrong AP, Miller RE, Jones JC, Zhang J, Keller ET, Dougall WC. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. Prostate 2007;68:92\u2013104.","journal-title":"Prostate"},{"key":"841_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/path.1190","volume":"198","author":"O Kudo","year":"2002","unstructured":"Kudo O, Fujikawa Y, Itonaga I, Sabokbar A, Torisu T, Athanasou NA. Proinflammatory cytokine (TNF\u03b1\/IL-1\u03b1) induction of human osteoclast formation. J Pathol 2002;198:220\u20137.","journal-title":"J Pathol"},{"key":"841_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010;18:11\u201322.","journal-title":"Cancer Cell"},{"key":"841_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-64","volume":"7","author":"UR Chandran","year":"2007","unstructured":"Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, Liang W, et al. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 2007;7:64.","journal-title":"BMC Cancer"},{"key":"841_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nm.4053","volume":"22","author":"A Kumar","year":"2016","unstructured":"Kumar A, Coleman I, Morrissey C, Zhang X, True LD, Gulati R, et al. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. Nat Med 2016;22:369\u201378.","journal-title":"Nat Med"},{"key":"841_CR25","first-page":"758","volume":"174","author":"DA Quigley","year":"2018","unstructured":"Quigley DA, Dang HX, Zhao SG, Lloyd P, Aggarwal R, Alumkal JJ, et al. Genomic hallmarks and structural variation in metastatic prostate. Cancer Cell 2018;174:758\u2013769.e9.","journal-title":"Cancer Cell"},{"key":"841_CR26","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson D, Van Allen EM, Wu Y-M, Schultz N, Lonigro RJ, Mosquera J-M, et al. Integrative clinical genomics of advanced prostate cancer. Cell 2015;161:1215\u201328. May","journal-title":"Cell"},{"key":"841_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0022-2836(02)01449-3","volume":"326","author":"X Chen","year":"2003","unstructured":"Chen X, Whitney EM, Gao SY, Yang VW. Transcriptional profiling of Kr\u00fcppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. J Mol Biol 2003;326:665\u201377.","journal-title":"J Mol Biol"},{"key":"841_CR28","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/ncb1314","volume":"7","author":"BD Rowland","year":"2005","unstructured":"Rowland BD, Bernards R, Peeper DS. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 2005;7:1074\u201382.","journal-title":"Nat Cell Biol"},{"key":"841_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/sj.onc.1207067","volume":"23","author":"W Zhao","year":"2004","unstructured":"Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, Yang VW. Identification of Kr\u00fcppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 2004;23:395\u2013402.","journal-title":"Oncogene"},{"key":"841_CR30","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-04-3619","volume":"65","author":"D Wei","year":"2005","unstructured":"Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, et al. Drastic down-regulation of Kr\u00fcppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 2005;65:2746\u201354.","journal-title":"Cancer Res"},{"key":"841_CR31","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.stem.2019.01.003","volume":"24","author":"A Sastre-Perona","year":"2019","unstructured":"Sastre-Perona A, Hoang-Phou S, Leitner MC, Okuniewska M, Meehan S, Schober M. De novo PITX1 expression controls bi-stable transcriptional circuits to govern self-renewal and differentiation in squamous cell carcinoma. Cell Stem Cell 2019;24:390\u2013404.","journal-title":"Cell Stem Cell"},{"key":"841_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075092","volume":"8","author":"A Fradet","year":"2013","unstructured":"Fradet A, Sorel H, Depalle B, Serre CM, Farlay D, Turtoi A, et al. A new murine model of osteoblastic\/osteolytic lesions from human androgen-resistant prostate cancer. PLoS ONE 2013;8:e75092.","journal-title":"PLoS ONE"},{"key":"841_CR33","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1172\/JCI33637C1","volume":"118","author":"ZG Li","year":"2008","unstructured":"Li ZG, Mathew P, Yang J, Starbuck MW, Zurita AJ, Liu J, et al. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest 2008;118:2697\u2013710.","journal-title":"J Clin Invest"},{"key":"841_CR34","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/pros.20408","volume":"66","author":"BE LeRoy","year":"2006","unstructured":"LeRoy BE, Thudi NK, Nadella MVP, Toribio RE, Tannehill-Gregg SH, van Bokhoven A, et al. New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft. Prostate 2006;66:1213\u201322.","journal-title":"Prostate"},{"key":"841_CR35","doi-asserted-by":"publisher","first-page":"25706","DOI":"10.1074\/jbc.M112.361360","volume":"287","author":"T Yoshida","year":"2012","unstructured":"Yoshida T, Yamashita M, Hayashi M. Kruppel-like factor 4 contributes to high phosphate-induced phenotypic switching of vascular smooth muscle cells into osteogenic cells. J Biol Chem 2012;287:25706\u201314.","journal-title":"J Biol Chem"},{"key":"841_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/813894","volume":"2012","author":"M Barba","year":"2012","unstructured":"Barba M, Pirozzi F, Saulnier N, Vitali T, Natale MT, Logroscino G, et al. Lim mineralization protein 3 induces the osteogenic differentiation of human amniotic fluid stromal cells through kruppel-like factor-4 downregulation and further bone-specific gene expression. J Biomed Biotechnol 2012;2012:1\u201311.","journal-title":"J Biomed Biotechnol"},{"key":"841_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337\u201342.","journal-title":"Nature"},{"key":"841_CR38","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2174\/1566524011313040012","volume":"13","author":"JL Sottnik","year":"2013","unstructured":"Sottnik JL, Keller ET. Understanding and targeting osteoclastic activity in prostate cancer bone metastases. Curr Mol Med. 2013;13:626\u201339.","journal-title":"Curr Mol Med"},{"key":"841_CR39","doi-asserted-by":"publisher","first-page":"33132","DOI":"10.1074\/jbc.M500608200","volume":"280","author":"T Gaur","year":"2005","unstructured":"Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PVN, Komm BS, et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 2005;280:33132\u201340.","journal-title":"J Biol Chem"},{"key":"841_CR40","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.matbio.2007.05.004","volume":"26","author":"DR Hopkins","year":"2007","unstructured":"Hopkins DR, Keles S, Greenspan DS. The bone morphogenetic protein 1\/Tolloid-like metalloproteinases. Matrix Biol 2007;26:508\u201323.","journal-title":"Matrix Biol"},{"key":"841_CR41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bbrc.2008.08.139","volume":"376","author":"T Tsuji","year":"2008","unstructured":"Tsuji T, Kondo E, Yasoda A, Inamoto M, Kiyosu C, Nakao K, et al. Hypomorphic mutation in mouse Nppc gene causes retarded bone growth due to impaired endochondral ossification. Biochem Biophys Res Commun 2008;376:186\u201390.","journal-title":"Biochem Biophys Res Commun"},{"key":"841_CR42","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1083\/jcb.200906014","volume":"187","author":"N Rucci","year":"2009","unstructured":"Rucci N, Rufo A, Alamanou M, Capulli M, Del Fattore A, \u00c5hrman E, et al. The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-\u03baB inhibitor that impairs osteoclastogenesis. J Cell Biol 2009;187:669\u201383.","journal-title":"J Cell Biol"},{"key":"841_CR43","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1242\/dev.155598","volume":"144","author":"T Uchimura","year":"2017","unstructured":"Uchimura T, Hollander JM, Nakamura DS, Liu Z, Rosen CJ, Georgakoudi I, et al. An essential role for IGF2 in cartilage development and glucose metabolism during postnatal long bone growth. Development 2017;144:3533\u201346.","journal-title":"Development"},{"key":"841_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1302\/2046-3758.76.BJR-2017-0140.R2","volume":"7","author":"MW Morcos","year":"2018","unstructured":"Morcos MW, Al-Jallad H, Li J, Farquharson C, Mill\u00e1n JL, Hamdy RC, et al. PHOSPHO1 is essential for normal bone fracture healing. Bone Jt Res 2018;7:397\u2013405.","journal-title":"Bone Jt Res"},{"key":"841_CR45","first-page":"48","volume":"5","author":"B Osta","year":"2014","unstructured":"Osta B, Benedetti G, Miossec P. Classical and paradoxical effects of TNF-\u03b1 on bone homeostasis. Front Immunol 2014;5:48.","journal-title":"Front Immunol"},{"key":"841_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3858\/emm.2010.42.6.045","volume":"42","author":"H-L Lee","year":"2010","unstructured":"Lee H-L, Yi T, Woo KM, Ryoo H-M, Kim G-S, Baek J-H. Msx2 mediates the inhibitory action of TNF-\u03b1 on osteoblast differentiation. Exp Mol Med 2010;42:437\u20139.","journal-title":"Exp Mol Med"},{"key":"841_CR47","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 2013;8:2281\u2013308.","journal-title":"Nat Protoc"},{"key":"841_CR48","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.stem.2008.08.014","volume":"3","author":"D Hockemeyer","year":"2008","unstructured":"Hockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R. A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 2008;3:346\u201353.","journal-title":"Cell Stem Cell"},{"key":"841_CR49","first-page":"1","volume":"92","author":"S Borowicz","year":"2014","unstructured":"Borowicz S, Van Scoyk M, Avasarala S, Karuppusamy Rathinam MK, Tauler J, Bikkavilli RK, et al. The soft agar colony formation assay. J Vis Exp 2014;92:1\u20136.","journal-title":"J Vis Exp"},{"key":"841_CR50","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, M\u00fcller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Min Res 2010;25:1468\u201386.","journal-title":"J Bone Min Res"},{"key":"841_CR51","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bone.2006.10.027","volume":"40","author":"P Leucht","year":"2007","unstructured":"Leucht P, Kim J-B, Wazen R, Currey JA, Nanci A, Brunski JB, et al. Effect of mechanical stimuli on skeletal regeneration around implants. Bone 2007;40:919\u201330.","journal-title":"Bone"},{"key":"841_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2012","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2012;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"841_CR53","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 2015;31:166\u20139.","journal-title":"Bioinformatics"},{"key":"841_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol 2010;11:R106.","journal-title":"Genome Biol"},{"key":"841_CR55","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010;26:841\u20132.","journal-title":"Bioinformatics"},{"key":"841_CR56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"841_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"DW Huang","year":"2008","unstructured":"Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2008;37:1\u201313.","journal-title":"Nucleic Acids Res"},{"key":"841_CR58","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"841_CR59","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267\u201373.","journal-title":"Nat Genet"},{"key":"841_CR60","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"841_CR61","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012;2:401\u20134.","journal-title":"Cancer Discov"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0841-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0841-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0841-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:16:21Z","timestamp":1684617381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-0841-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":61,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["841"],"URL":"https:\/\/doi.org\/10.1038\/s41388-019-0841-3","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"9 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}